Medical Properties Trust Inc (MPW) Shares See Highest Trading Level at $4.21

As of close of business last night, Medical Properties Trust Inc’s stock clocked out at $4.21, up 0.96% from its previous closing price of $4.17. In other words, the price has increased by $+0.0400 from its previous closing price. On the day, 20390855 shares were traded. MPW stock price reached its highest trading level at $4.3600 during the session, while it also had its lowest trading level at $4.1635.

Ratios:

To gain a deeper understanding of MPW’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.09 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.57. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 1.32.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on January 30, 2024, initiated with a Sell rating and assigned the stock a target price of $2.

Stifel Downgraded its Buy to Hold on November 10, 2023, whereas the target price for the stock was revised from $12 to $4.50.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MPW now has a Market Capitalization of 2.50B and an Enterprise Value of 12.47B. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.89 while its Price-to-Book (P/B) ratio in mrq is 0.33. Its current Enterprise Value per Revenue stands at 14.30 whereas that against EBITDA is 38.04.

Stock Price History:

Over the past 52 weeks, MPW has reached a high of $10.74, while it has fallen to a 52-week low of $2.92. The 50-Day Moving Average of the stock is 3.8486, while the 200-Day Moving Average is calculated to be 6.2305.

Shares Statistics:

It appears that MPW traded 22.54M shares on average per day over the past three months and 20.13M shares per day over the past ten days. A total of 598.99M shares are outstanding, with a floating share count of 588.57M. Insiders hold about 1.74% of the company’s shares, while institutions hold 73.53% stake in the company. Shares short for MPW as of Feb 15, 2024 were 197.33M with a Short Ratio of 8.76, compared to 164.89M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 32.94% and a Short% of Float of 45.87%.

Dividends & Splits

With its trailing 12-month dividend rate of 0.88, MPW has a forward annual dividend rate of 0.88. Against a Trailing Annual Dividend Yield of 21.10%, it implies a Forward Annual Dividend Yield of 21.10%. The stock’s 5-year Average Dividend Yield is 8.09.

Earnings Estimates

As of right now, 5 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.13 for the current quarter, with a high estimate of $0.21 and a low estimate of $0.04, while EPS last year was $0.05. The consensus estimate for the next quarter is $0.16, with high estimates of $0.22 and low estimates of $0.13.

Analysts are recommending an EPS of between $1.37 and $0.48 for the fiscal current year, implying an average EPS of $0.73. EPS for the following year is $0.74, with 6 analysts recommending between $1.35 and $0.5.

Revenue Estimates

In the current quarter, 6 analysts expect revenue to total $303.66M. It ranges from a high estimate of $346.13M to a low estimate of $257.85M. As of the current estimate, Medical Properties Trust Inc’s year-ago sales were $354.55M, an estimated decrease of -14.40% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $327.1M, a decrease of -3.10% over than the figure of -$14.40% in the same quarter last year. There is a high estimate of $358.6M for the next quarter, whereas the lowest estimate is $277.6M.

A total of 9 analysts have provided revenue estimates for MPW’s current fiscal year. The highest revenue estimate was $1.38B, while the lowest revenue estimate was $1.1B, resulting in an average revenue estimate of $1.24B. In the same quarter a year ago, actual revenue was $1.33B, down -6.60% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $1.19B in the next fiscal year. The high estimate is $1.35B and the low estimate is $1.03B. The average revenue growth estimate for next year is down -4.20% from the average revenue estimate for this year.

Most Popular

[the_ad id="945"]